Dabrafenib-impurities | Pharmaffiliates

dabrafenib and its Impurities

Dabrafenib is a reversible ATP-competitive kinase inhibitor and targets the MAPK pathway. It is used alone or in combination with another medication to treat a type of skin cancer.. Reference standards of Dabrafenib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 5 results for dabrafenib Impurities
PA 31 06000

Dabrafenib - API

Dabrafenib


  • Catalogue No.:PA 31 06000

  • CAS :

    1195765-45-7

  • Molecular Formula : C23H20F3N5O2S2

  • Molecular Weight : 519.56

PA 31 06510

3-Bromo-2-fluorobenzoic Acid

3-Bromo-2-fluorobenzoic Acid


  • Catalogue No.:PA 31 06510

  • CAS :

    161957-56-8

  • Molecular Formula : C7H4BrFO2

  • Molecular Weight : 219.01

PA 31 06520

Dabrafenib Mesylate

Dabrafenib Mesylate


  • Catalogue No.:PA 31 06520

  • CAS :

    1195768-06-9

  • Molecular Formula : C24H24F3N5O5S3

  • Molecular Weight : 615.67

PA 31 06530

2,6-Difluorobenzenesulfonyl Chloride

2,6-Difluorobenzenesulfonyl Chloride


  • Catalogue No.:PA 31 06530

  • CAS :

    60230-36-6

  • Molecular Formula : C6H3ClF2O2S

  • Molecular Weight : 212.6

PA 31 06540

2,2-Dimethylthiopropionamide

2,2-Dimethylthiopropionamide


  • Catalogue No.:PA 31 06540

  • CAS :

    630-22-8

  • Molecular Formula : C5H11NS

  • Molecular Weight : 117.21